The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Contribution of Coagulases towards Staphylococcus aureus Disease and Protective Immunity
Open accessAbstract
The bacterial pathogen Staphylococcus aureus seeds abscesses in host tissues to replicate at the center of these lesions, protected from host immune cells via a pseudocapsule. Using histochemical staining, we identified prothrombin and fibrin within abscesses and pseudocapsules. S. aureus secretes two clotting factors, coagulase (Coa) and von Willebrand factor binding protein (vWbp). We report here that Coa and vWbp together are required for the formation of abscesses. Coa and vWbp promote the non-proteolytic activation of prothrombin and cleavage of fibrinogen, reactions that are inhibited with specific antibody against each of these molecules. Coa and vWbp specific antibodies confer protection against abscess formation and S. aureus lethal bacteremia, suggesting that coagulases function as protective antigens for a staphylococcal vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues
Cheng, A. G., Kim, H. K., Burts, M. L., Krausz, T., Schneewind, O., & Missiakas, D. M. (2009) · The FASEB Journal · doi:10.1096/fj.09-135467 · Cited by 437
Self-citationRetracted[6] Use of T7 RNA polymerase to direct expression of cloned genes
William Studier, F., Rosenberg, A. H., Dunn, J. J., & Dubendorff, J. W. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)85008-c · Cited by 6,562
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726 · cited 1×
“Staphylococcal bacteremia is a frequent cause of human morbidity and mortality in hospital settings [34].”
BackgroundStaphylococcal Coagulase: Mode of Action and Antigenicity
DUTHIE, E. S., & LORENZ, L. L. (1952) · Microbiology · doi:10.1099/00221287-6-1-2-95 · Cited by 622
Allelic replacement in Staphylococcus aureus with inducible counter-selection
Bae, T., & Schneewind, O. (2006) · Plasmid · doi:10.1016/j.plasmid.2005.05.005 · Cited by 621
Self-citationPassage of Heme-Iron Across the Envelope of Staphylococcus aureus
Mazmanian, S. K., Skaar, E. P., Gaspar, A. H., Humayun, M., Gornicki, P., Jelenska, J., Joachmiak, A., Missiakas, D. M., & Schneewind, O. (2003) · Science · doi:10.1126/science.1081147 · Cited by 593
Self-citationBaba, T., Bae, T., Schneewind, O., Takeuchi, F., & Hiramatsu, K. (2008) · Journal of Bacteriology · doi:10.1128/jb.01000-07 · Cited by 563
Self-citationSorting of protein a to the staphylococcal cell wall
Schneewind, O., Model, P., & Fischetti, V. A. (1992) · Cell · doi:10.1016/0092-8674(92)90101-h · Cited by 552
Self-citationMolecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus
McDevitt, D., Francois, P., Vaudaux, P., & Foster, T. J. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00304.x · Cited by 546
Cell wall sorting signals in surface proteins of gram‐positive bacteria.
Schneewind, O., Mihaylova‐Petkov, D., & Model, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06169.x · Cited by 426
Self-citationClumping factor B (ClfB), a new surface‐located fibrinogen‐binding adhesin of Staphylococcus aureus
Ní Eidhin, D., Perkins, S., Francois, P., Vaudaux, P., Höök, M., & Foster, T. J. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01050.x · Cited by 418
Moreillon, P., Entenza, J. M., Francioli, P., McDevitt, D., Foster, T. J., François, P., & Vaudaux, P. (1995) · Infection and Immunity · doi:10.1128/iai.63.12.4738-4743.1995 · Cited by 396
Kennedy, A. D., Otto, M., Braughton, K. R., Whitney, A. R., Chen, L., Mathema, B., Mediavilla, J. R., Byrne, K. A., Parkins, L. D., Tenover, F. C., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710217105 · Cited by 387
Vaccine assembly from surface proteins of Staphylococcus aureus
Stranger-Jones, Y. K., Bae, T., & Schneewind, O. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606863103 · Cited by 309
Self-citationKuklin, N. A., Clark, D. J., Secore, S., Cook, J., Cope, L. D., McNeely, T., Noble, L., Brown, M. J., Zorman, J. K., Wang, X. M., et al. (2006) · Infection and Immunity · doi:10.1128/iai.74.4.2215-2223.2006 · Cited by 264 · cited 1×
“The possibility that IsdB may raise vaccine protection from staphylococcal diseases in humans is currently being tested [10].”
BackgroundStaphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation
Friedrich, R., Panizzi, P., Fuentes-Prior, P., Richter, K., Verhamme, I., Anderson, P. J., Kawabata, S.-I., Huber, R., Bode, W., & Bock, P. E. (2003) · Nature · doi:10.1038/nature01962 · Cited by 263
Staphylococcus aureus synthesizes adenosine to escape host immune responses
Thammavongsa, V., Kern, J. W., Missiakas, D. M., & Schneewind, O. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090097 · Cited by 252
Self-citationNontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice
Kim, H. K., Cheng, A. G., Kim, H.-Y., Missiakas, D. M., & Schneewind, O. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092514 · Cited by 203
Self-citationHarvey, R. P., Degryse, E., Stefani, L., Schamber, F., Cazenave, J. P., Courtney, M., Tolstoshev, P., & Lecocq, J. P. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.4.1084 · Cited by 199
Death by a B Cell Superantigen
Goodyear, C. S., & Silverman, G. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020552 · Cited by 192
Differential Target Gene Activation by the Staphylococcus aureus Two-Component System saeRS
Mainiero, M., Goerke, C., Geiger, T., Gonser, C. E., Herbert, S., & Wolz, C. (2009) · Journal of Bacteriology · doi:10.1128/jb.01242-09 · Cited by 156
Phonimdaeng, P., O’Reilly, M., Nowlan, P., Bramley, A. J., & Foster, T. J. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb00606.x · Cited by 155
Hussain, M., Becker, K., von Eiff, C., Schrenzel, J., Peters, G., & Herrmann, M. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6778-6786.2001 · Cited by 149
Klevens, R. M., Edwards, J. R., Gaynes, R. P., & System, N. N. I. S. (2008) · Clinical Infectious Diseases · doi:10.1086/591698 · Cited by 136
Bjerketorp, J., Nilsson, M., Ljungh, Å., Flock, J., Jacobsson, K., & Frykberg, L. (2002) · Microbiology · doi:10.1099/00221287-148-7-2037 · Cited by 109
Virulence of Staphylococcus aureus mutants altered in type 5 capsule production
Albus, A., Arbeit, R. D., & Lee, J. C. (1991) · Infection and Immunity · doi:10.1128/iai.59.3.1008-1014.1991 · Cited by 92
Staphylococcal vaccines and immunotherapy: to dream the impossible dream?
Projan, S., Nesin, M., & Dunman, P. M. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.005 · Cited by 88
Watanabe, S., Ito, T., Sasaki, T., Li, S., Uchiyama, I., Kozue, K., Kikuchi, K., Skov, R. L., & Hiramatsu, K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005714 · Cited by 88
The von Willebrand factor-binding protein (vWbp) of Staphylococcus aureus is a coagulase
Bjerketorp, J. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.03.040 · Cited by 78
The von Willebrand factor-binding protein (vWbp) ofStaphylococcus aureusis a coagulase
Bjerketorp, J., Jacobsson, K., & Frykberg, L. (2004) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2004.tb09549.x · Cited by 76
Fibrinogen Substrate Recognition by Staphylocoagulase·(Pro)thrombin Complexes
Panizzi, P. R., Friedrich, R., Fuentes‐Prior, P., Richter, K., BOCK, P. E., & Bode, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507956200 · Cited by 75
Geoghegan, J. A., Ganesh, V. K., Smeds, E., Liang, X., Höök, M., & Foster, T. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.062208 · Cited by 68
Palma, M., Wade, D. C., Flock, M., & Flock, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13177 · Cited by 67
Rothfork, J. M., Dessus-Babus, S., van Wamel, W. J. B., Cheung, A. L., & Gresham, H. D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5389 · Cited by 61
DeBord, K. L., Anderson, D. M., Marketon, M. M., Overheim, K. A., DePaolo, R. W., Ciletti, N. A., Jabrì, B., & Schneewind, O. (2006) · Infection and Immunity · doi:10.1128/iai.01860-05 · Cited by 60
Self-citationHeilmann, C., Herrmann, M., Kehrel, B. E., & Peters, G. (2002) · The Journal of Infectious Diseases · doi:10.1086/341081 · Cited by 50
CAPSULATION, PSEUDOCAPSULATION, AND THE SOMATIC ANTIGENS OF THE SURFACE OF STAPHYLOCOCCUS AUREUS
Mudd, S. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb11628.x · Cited by 26
Cited by
Neutrophil extracellular traps in immunity and disease
Papayannopoulos, V. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.105 · Cited by 3,397
Thrombosis as an intravascular effector of innate immunity
Engelmann, B., & Massberg, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3345 · Cited by 1,989
Pathogenicity and virulence of Staphylococcus aureus
Cheung, G. Y. C., Bae, J. S., & Otto, M. (2021) · Virulence · doi:10.1080/21505594.2021.1878688 · Cited by 1,380
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Bonaventura, A., Vecchié, A., Dagna, L., Martinod, K., Dixon, D. L., Van Tassell, B. W., Dentali, F., Montecucco, F., Massberg, S., Levi, M., et al. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00536-9 · Cited by 987
Otto, M. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.11.004 · Cited by 643
Metadata
- Authors
- Cheng, A. G., McAdow, M., Kim, H. K., Bae, T., Missiakas, D. M., & Schneewind, O.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-08-05
- Volume
- 6
- Issue
- 8
- Pages
- e1001036
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2068041880
- Cited by
- 324
- References
- 38
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.